

Over the last 7 days, the Healthcare industry has dropped 2.1%, driven by Novartis declining 3.5%. On the other hand Galderma Group is actually up 8.4%. As for the longer term, the industry's performance has been flat for the past year. As for the next few years, earnings are expected to grow by 14% per annum.
Has the Swiss Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 04 Nov 2025 | CHF 603.0b | CHF 155.4b | CHF 25.0b | 30.1x | 24.2x | 3.9x |
| Thu, 02 Oct 2025 | CHF 622.9b | CHF 153.6b | CHF 24.2b | 32x | 25.7x | 4.1x |
| Sat, 30 Aug 2025 | CHF 610.9b | CHF 153.9b | CHF 24.3b | 33.2x | 25.2x | 4x |
| Mon, 28 Jul 2025 | CHF 601.5b | CHF 152.9b | CHF 24.1b | 31.2x | 25x | 3.9x |
| Wed, 25 Jun 2025 | CHF 584.1b | CHF 150.5b | CHF 22.3b | 30.4x | 26.2x | 3.9x |
| Fri, 23 May 2025 | CHF 574.3b | CHF 152.2b | CHF 22.6b | 30.9x | 25.4x | 3.8x |
| Sun, 20 Apr 2025 | CHF 545.7b | CHF 149.9b | CHF 21.8b | 25.9x | 25.1x | 3.6x |
| Tue, 18 Mar 2025 | CHF 629.0b | CHF 154.8b | CHF 22.4b | 31.6x | 28.1x | 4.1x |
| Thu, 13 Feb 2025 | CHF 630.5b | CHF 156.6b | CHF 22.5b | 30x | 28x | 4x |
| Sat, 11 Jan 2025 | CHF 589.7b | CHF 153.6b | CHF 24.7b | 30.1x | 23.9x | 3.8x |
| Mon, 09 Dec 2024 | CHF 571.1b | CHF 150.7b | CHF 24.2b | 28.9x | 23.6x | 3.8x |
| Wed, 06 Nov 2024 | CHF 595.8b | CHF 149.3b | CHF 24.0b | 29.9x | 24.8x | 4x |
| Fri, 04 Oct 2024 | CHF 601.1b | CHF 147.6b | CHF 22.4b | 32.9x | 26.8x | 4.1x |
| Sun, 01 Sep 2024 | CHF 631.7b | CHF 147.3b | CHF 22.4b | 32.7x | 28.3x | 4.3x |
| Tue, 30 Jul 2024 | CHF 615.4b | CHF 149.3b | CHF 22.6b | 31.7x | 27.3x | 4.1x |
| Thu, 27 Jun 2024 | CHF 576.8b | CHF 148.9b | CHF 22.7b | 35.1x | 25.4x | 3.9x |
| Sat, 25 May 2024 | CHF 557.3b | CHF 150.2b | CHF 22.9b | 33.6x | 24.3x | 3.7x |
| Mon, 22 Apr 2024 | CHF 539.2b | CHF 145.0b | CHF 22.3b | 35.3x | 24.2x | 3.7x |
| Wed, 20 Mar 2024 | CHF 532.7b | CHF 143.6b | CHF 22.2b | 37.3x | 24x | 3.7x |
| Fri, 16 Feb 2024 | CHF 518.3b | CHF 142.7b | CHF 22.4b | 32.9x | 23.2x | 3.6x |
| Sun, 14 Jan 2024 | CHF 544.6b | CHF 151.4b | CHF 21.8b | 27.5x | 25x | 3.6x |
| Tue, 12 Dec 2023 | CHF 524.2b | CHF 153.4b | CHF 22.0b | 25.5x | 23.8x | 3.4x |
| Thu, 09 Nov 2023 | CHF 506.0b | CHF 154.7b | CHF 22.1b | 23.8x | 22.9x | 3.3x |
| Sat, 07 Oct 2023 | CHF 532.1b | CHF 145.7b | CHF 21.2b | 31.9x | 25.1x | 3.7x |
| Mon, 04 Sep 2023 | CHF 545.5b | CHF 144.3b | CHF 21.1b | 29.8x | 25.8x | 3.8x |
| Wed, 02 Aug 2023 | CHF 561.4b | CHF 146.7b | CHF 22.5b | 36.5x | 24.9x | 3.8x |
| Fri, 30 Jun 2023 | CHF 560.7b | CHF 147.4b | CHF 22.3b | 35x | 25.2x | 3.8x |
| Sun, 28 May 2023 | CHF 579.0b | CHF 147.7b | CHF 22.3b | 35x | 26x | 3.9x |
| Tue, 25 Apr 2023 | CHF 590.1b | CHF 146.2b | CHF 22.3b | 34.2x | 26.5x | 4x |
| Thu, 23 Mar 2023 | CHF 532.8b | CHF 148.2b | CHF 22.5b | 30.8x | 23.6x | 3.6x |
| Sat, 18 Feb 2023 | CHF 547.3b | CHF 148.1b | CHF 22.8b | 32.2x | 24x | 3.7x |
| Mon, 16 Jan 2023 | CHF 567.5b | CHF 148.6b | CHF 38.1b | 30.7x | 14.9x | 3.8x |
| Wed, 14 Dec 2022 | CHF 578.8b | CHF 148.6b | CHF 38.1b | 31.7x | 15.2x | 3.9x |
| Fri, 11 Nov 2022 | CHF 591.9b | CHF 150.8b | CHF 38.9b | 29x | 15.2x | 3.9x |
15.2x
Which industries have driven the changes within the Swiss Healthcare sector?
| CH Market | -1.66% | |
| Healthcare | -2.06% | |
| Biotech | 1.77% | |
| Medical Equipment | -0.10% | |
| Healthtech | -1.64% | |
| Pharma | -1.84% | |
| Healthcare Services | -3.25% | |
| Life Sciences | -6.66% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NOVN Novartis | CHF 101.48 | 2.6% +CHF 5.0b | 8.0% | PE16.7x | |
| GALD Galderma Group | CHF 153.30 | 7.3% +CHF 2.5b | 85.1% | PE119x | |
| ROG Roche Holding | CHF 264.00 | 1.1% +CHF 2.5b | -1.6% | PE23.8x | |
| SDZ Sandoz Group | CHF 54.98 | 10.6% +CHF 2.3b | 37.7% | PE128.9x | |
| STMN Straumann Holding | CHF 98.14 | 12.1% +CHF 1.7b | -16.9% | PE36.6x |